nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—area postrema—multiple sclerosis	0.0894	0.446	CbGeAlD
Tapentadol—CYP2D6—Fingolimod—multiple sclerosis	0.0577	0.427	CbGbCtD
Tapentadol—CYP2C19—Prednisone—multiple sclerosis	0.0296	0.219	CbGbCtD
Tapentadol—CYP2C19—Dexamethasone—multiple sclerosis	0.0185	0.137	CbGbCtD
Tapentadol—CYP2C9—Dexamethasone—multiple sclerosis	0.0154	0.114	CbGbCtD
Tapentadol—CYP2D6—Dexamethasone—multiple sclerosis	0.0141	0.104	CbGbCtD
Tapentadol—HTR3A—nerve—multiple sclerosis	0.0116	0.0581	CbGeAlD
Tapentadol—OPRM1—nerve—multiple sclerosis	0.0107	0.0532	CbGeAlD
Tapentadol—Edrophonium—BCHE—multiple sclerosis	0.00845	0.518	CrCbGaD
Tapentadol—Rivastigmine—BCHE—multiple sclerosis	0.00785	0.482	CrCbGaD
Tapentadol—SLC6A2—nerve—multiple sclerosis	0.00781	0.039	CbGeAlD
Tapentadol—HTR3A—brainstem—multiple sclerosis	0.005	0.0249	CbGeAlD
Tapentadol—OPRM1—brainstem—multiple sclerosis	0.00458	0.0229	CbGeAlD
Tapentadol—SLC6A4—brainstem—multiple sclerosis	0.00381	0.019	CbGeAlD
Tapentadol—OPRD1—nervous system—multiple sclerosis	0.00352	0.0176	CbGeAlD
Tapentadol—OPRD1—central nervous system—multiple sclerosis	0.00339	0.0169	CbGeAlD
Tapentadol—OPRK1—nervous system—multiple sclerosis	0.00337	0.0168	CbGeAlD
Tapentadol—SLC6A2—brainstem—multiple sclerosis	0.00335	0.0167	CbGeAlD
Tapentadol—OPRK1—central nervous system—multiple sclerosis	0.00325	0.0162	CbGeAlD
Tapentadol—OPRK1—cerebellum—multiple sclerosis	0.00317	0.0158	CbGeAlD
Tapentadol—OPRM1—midbrain—multiple sclerosis	0.00292	0.0146	CbGeAlD
Tapentadol—OPRM1—spinal cord—multiple sclerosis	0.00285	0.0142	CbGeAlD
Tapentadol—OPRD1—brain—multiple sclerosis	0.00269	0.0134	CbGeAlD
Tapentadol—HTR3A—nervous system—multiple sclerosis	0.00262	0.0131	CbGeAlD
Tapentadol—OPRK1—brain—multiple sclerosis	0.00258	0.0129	CbGeAlD
Tapentadol—HTR3A—central nervous system—multiple sclerosis	0.00252	0.0126	CbGeAlD
Tapentadol—SLC6A4—midbrain—multiple sclerosis	0.00243	0.0121	CbGeAlD
Tapentadol—OPRM1—nervous system—multiple sclerosis	0.0024	0.012	CbGeAlD
Tapentadol—SLC6A4—spinal cord—multiple sclerosis	0.00237	0.0118	CbGeAlD
Tapentadol—SLC6A2—medulla oblongata—multiple sclerosis	0.00234	0.0117	CbGeAlD
Tapentadol—OPRM1—central nervous system—multiple sclerosis	0.00231	0.0115	CbGeAlD
Tapentadol—HTR3A—brain—multiple sclerosis	0.002	0.00998	CbGeAlD
Tapentadol—SLC6A4—nervous system—multiple sclerosis	0.002	0.00996	CbGeAlD
Tapentadol—SLC6A4—central nervous system—multiple sclerosis	0.00192	0.00959	CbGeAlD
Tapentadol—CYP2D6—brainstem—multiple sclerosis	0.00184	0.00916	CbGeAlD
Tapentadol—OPRM1—brain—multiple sclerosis	0.00183	0.00915	CbGeAlD
Tapentadol—SLC6A2—nervous system—multiple sclerosis	0.00176	0.00877	CbGeAlD
Tapentadol—SLC6A2—central nervous system—multiple sclerosis	0.00169	0.00844	CbGeAlD
Tapentadol—SLC6A4—brain—multiple sclerosis	0.00153	0.00761	CbGeAlD
Tapentadol—SLC6A2—brain—multiple sclerosis	0.00134	0.0067	CbGeAlD
Tapentadol—CYP2D6—nervous system—multiple sclerosis	0.000962	0.0048	CbGeAlD
Tapentadol—CYP2D6—central nervous system—multiple sclerosis	0.000926	0.00462	CbGeAlD
Tapentadol—CYP2D6—cerebellum—multiple sclerosis	0.000905	0.00452	CbGeAlD
Tapentadol—CYP2D6—brain—multiple sclerosis	0.000735	0.00367	CbGeAlD
Tapentadol—Vertigo—Triamcinolone—multiple sclerosis	0.000691	0.00153	CcSEcCtD
Tapentadol—Syncope—Triamcinolone—multiple sclerosis	0.00069	0.00153	CcSEcCtD
Tapentadol—Vertigo—Methylprednisolone—multiple sclerosis	0.00069	0.00152	CcSEcCtD
Tapentadol—Syncope—Methylprednisolone—multiple sclerosis	0.000688	0.00152	CcSEcCtD
Tapentadol—Connective tissue disorder—Prednisone—multiple sclerosis	0.000686	0.00152	CcSEcCtD
Tapentadol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000686	0.00152	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000683	0.00151	CcSEcCtD
Tapentadol—Oedema—Prednisolone—multiple sclerosis	0.000683	0.00151	CcSEcCtD
Tapentadol—Dizziness—Azathioprine—multiple sclerosis	0.000681	0.0015	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000678	0.0015	CcSEcCtD
Tapentadol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000676	0.00149	CcSEcCtD
Tapentadol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000675	0.00149	CcSEcCtD
Tapentadol—Shock—Prednisolone—multiple sclerosis	0.000672	0.00148	CcSEcCtD
Tapentadol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000672	0.00148	CcSEcCtD
Tapentadol—Cough—Triamcinolone—multiple sclerosis	0.000671	0.00148	CcSEcCtD
Tapentadol—Convulsion—Triamcinolone—multiple sclerosis	0.000667	0.00147	CcSEcCtD
Tapentadol—Tachycardia—Prednisolone—multiple sclerosis	0.000666	0.00147	CcSEcCtD
Tapentadol—Convulsion—Methylprednisolone—multiple sclerosis	0.000665	0.00147	CcSEcCtD
Tapentadol—Urticaria—Mitoxantrone—multiple sclerosis	0.000661	0.00146	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00066	0.00146	CcSEcCtD
Tapentadol—Vomiting—Azathioprine—multiple sclerosis	0.000655	0.00145	CcSEcCtD
Tapentadol—Arthralgia—Methylprednisolone—multiple sclerosis	0.000653	0.00144	CcSEcCtD
Tapentadol—Eye disorder—Prednisone—multiple sclerosis	0.000653	0.00144	CcSEcCtD
Tapentadol—Anxiety—Methylprednisolone—multiple sclerosis	0.000651	0.00144	CcSEcCtD
Tapentadol—Infestation NOS—Methotrexate—multiple sclerosis	0.00065	0.00144	CcSEcCtD
Tapentadol—Infestation—Methotrexate—multiple sclerosis	0.00065	0.00144	CcSEcCtD
Tapentadol—Rash—Azathioprine—multiple sclerosis	0.000649	0.00143	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000649	0.00143	CcSEcCtD
Tapentadol—Dermatitis—Azathioprine—multiple sclerosis	0.000648	0.00143	CcSEcCtD
Tapentadol—Depression—Methotrexate—multiple sclerosis	0.000648	0.00143	CcSEcCtD
Tapentadol—Headache—Azathioprine—multiple sclerosis	0.000645	0.00143	CcSEcCtD
Tapentadol—Dry mouth—Triamcinolone—multiple sclerosis	0.000641	0.00142	CcSEcCtD
Tapentadol—Angioedema—Betamethasone—multiple sclerosis	0.000638	0.00141	CcSEcCtD
Tapentadol—Angioedema—Dexamethasone—multiple sclerosis	0.000638	0.00141	CcSEcCtD
Tapentadol—Angiopathy—Prednisone—multiple sclerosis	0.000634	0.0014	CcSEcCtD
Tapentadol—Confusional state—Methylprednisolone—multiple sclerosis	0.000632	0.0014	CcSEcCtD
Tapentadol—Immune system disorder—Prednisone—multiple sclerosis	0.000631	0.00139	CcSEcCtD
Tapentadol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000628	0.00139	CcSEcCtD
Tapentadol—Oedema—Triamcinolone—multiple sclerosis	0.000628	0.00139	CcSEcCtD
Tapentadol—Vertigo—Dexamethasone—multiple sclerosis	0.000627	0.00139	CcSEcCtD
Tapentadol—Vertigo—Betamethasone—multiple sclerosis	0.000627	0.00139	CcSEcCtD
Tapentadol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000626	0.00138	CcSEcCtD
Tapentadol—Syncope—Dexamethasone—multiple sclerosis	0.000626	0.00138	CcSEcCtD
Tapentadol—Syncope—Betamethasone—multiple sclerosis	0.000626	0.00138	CcSEcCtD
Tapentadol—Infection—Triamcinolone—multiple sclerosis	0.000624	0.00138	CcSEcCtD
Tapentadol—Infection—Methylprednisolone—multiple sclerosis	0.000622	0.00138	CcSEcCtD
Tapentadol—Shock—Triamcinolone—multiple sclerosis	0.000618	0.00137	CcSEcCtD
Tapentadol—Insomnia—Prednisolone—multiple sclerosis	0.000617	0.00137	CcSEcCtD
Tapentadol—Shock—Methylprednisolone—multiple sclerosis	0.000616	0.00136	CcSEcCtD
Tapentadol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000614	0.00136	CcSEcCtD
Tapentadol—Loss of consciousness—Betamethasone—multiple sclerosis	0.000613	0.00136	CcSEcCtD
Tapentadol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000613	0.00136	CcSEcCtD
Tapentadol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000613	0.00136	CcSEcCtD
Tapentadol—Paraesthesia—Prednisolone—multiple sclerosis	0.000613	0.00136	CcSEcCtD
Tapentadol—Tachycardia—Triamcinolone—multiple sclerosis	0.000613	0.00135	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—multiple sclerosis	0.000612	0.00135	CcSEcCtD
Tapentadol—Nausea—Azathioprine—multiple sclerosis	0.000611	0.00135	CcSEcCtD
Tapentadol—Tachycardia—Methylprednisolone—multiple sclerosis	0.000611	0.00135	CcSEcCtD
Tapentadol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000608	0.00135	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—multiple sclerosis	0.000608	0.00134	CcSEcCtD
Tapentadol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000607	0.00134	CcSEcCtD
Tapentadol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000606	0.00134	CcSEcCtD
Tapentadol—Convulsion—Dexamethasone—multiple sclerosis	0.000605	0.00134	CcSEcCtD
Tapentadol—Convulsion—Betamethasone—multiple sclerosis	0.000605	0.00134	CcSEcCtD
Tapentadol—Asthenia—Mitoxantrone—multiple sclerosis	0.000597	0.00132	CcSEcCtD
Tapentadol—Anxiety—Betamethasone—multiple sclerosis	0.000592	0.00131	CcSEcCtD
Tapentadol—Anxiety—Dexamethasone—multiple sclerosis	0.000592	0.00131	CcSEcCtD
Tapentadol—Hypotension—Methylprednisolone—multiple sclerosis	0.000585	0.00129	CcSEcCtD
Tapentadol—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000576	0.00127	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—multiple sclerosis	0.000573	0.00127	CcSEcCtD
Tapentadol—Urethral disorder—Methotrexate—multiple sclerosis	0.000572	0.00126	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000572	0.00126	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000571	0.00126	CcSEcCtD
Tapentadol—Oedema—Dexamethasone—multiple sclerosis	0.00057	0.00126	CcSEcCtD
Tapentadol—Oedema—Betamethasone—multiple sclerosis	0.00057	0.00126	CcSEcCtD
Tapentadol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00057	0.00126	CcSEcCtD
Tapentadol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00057	0.00126	CcSEcCtD
Tapentadol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000569	0.00126	CcSEcCtD
Tapentadol—Insomnia—Triamcinolone—multiple sclerosis	0.000568	0.00126	CcSEcCtD
Tapentadol—Insomnia—Methylprednisolone—multiple sclerosis	0.000567	0.00125	CcSEcCtD
Tapentadol—Infection—Betamethasone—multiple sclerosis	0.000566	0.00125	CcSEcCtD
Tapentadol—Infection—Dexamethasone—multiple sclerosis	0.000566	0.00125	CcSEcCtD
Tapentadol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000564	0.00125	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000563	0.00124	CcSEcCtD
Tapentadol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000563	0.00124	CcSEcCtD
Tapentadol—Visual impairment—Methotrexate—multiple sclerosis	0.000562	0.00124	CcSEcCtD
Tapentadol—Shock—Betamethasone—multiple sclerosis	0.00056	0.00124	CcSEcCtD
Tapentadol—Shock—Dexamethasone—multiple sclerosis	0.00056	0.00124	CcSEcCtD
Tapentadol—Dyspnoea—Triamcinolone—multiple sclerosis	0.00056	0.00124	CcSEcCtD
Tapentadol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000559	0.00124	CcSEcCtD
Tapentadol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000559	0.00124	CcSEcCtD
Tapentadol—Agitation—Prednisone—multiple sclerosis	0.000559	0.00123	CcSEcCtD
Tapentadol—Tachycardia—Dexamethasone—multiple sclerosis	0.000556	0.00123	CcSEcCtD
Tapentadol—Tachycardia—Betamethasone—multiple sclerosis	0.000556	0.00123	CcSEcCtD
Tapentadol—Angioedema—Prednisone—multiple sclerosis	0.000555	0.00123	CcSEcCtD
Tapentadol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000553	0.00122	CcSEcCtD
Tapentadol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000551	0.00122	CcSEcCtD
Tapentadol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000551	0.00122	CcSEcCtD
Tapentadol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000551	0.00122	CcSEcCtD
Tapentadol—Vertigo—Prednisone—multiple sclerosis	0.000546	0.00121	CcSEcCtD
Tapentadol—Eye disorder—Methotrexate—multiple sclerosis	0.000545	0.00121	CcSEcCtD
Tapentadol—Syncope—Prednisone—multiple sclerosis	0.000545	0.00121	CcSEcCtD
Tapentadol—Urticaria—Prednisolone—multiple sclerosis	0.000542	0.0012	CcSEcCtD
Tapentadol—Cardiac disorder—Methotrexate—multiple sclerosis	0.000542	0.0012	CcSEcCtD
Tapentadol—Fatigue—Triamcinolone—multiple sclerosis	0.000541	0.0012	CcSEcCtD
Tapentadol—Fatigue—Methylprednisolone—multiple sclerosis	0.00054	0.00119	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—multiple sclerosis	0.000534	0.00118	CcSEcCtD
Tapentadol—Hypotension—Dexamethasone—multiple sclerosis	0.000532	0.00118	CcSEcCtD
Tapentadol—Hypotension—Betamethasone—multiple sclerosis	0.000532	0.00118	CcSEcCtD
Tapentadol—Angiopathy—Methotrexate—multiple sclerosis	0.000529	0.00117	CcSEcCtD
Tapentadol—Vomiting—Mitoxantrone—multiple sclerosis	0.000529	0.00117	CcSEcCtD
Tapentadol—Immune system disorder—Methotrexate—multiple sclerosis	0.000527	0.00117	CcSEcCtD
Tapentadol—Convulsion—Prednisone—multiple sclerosis	0.000527	0.00116	CcSEcCtD
Tapentadol—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000526	0.00116	CcSEcCtD
Tapentadol—Rash—Mitoxantrone—multiple sclerosis	0.000525	0.00116	CcSEcCtD
Tapentadol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000524	0.00116	CcSEcCtD
Tapentadol—Chills—Methotrexate—multiple sclerosis	0.000524	0.00116	CcSEcCtD
Tapentadol—Headache—Mitoxantrone—multiple sclerosis	0.000521	0.00115	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000519	0.00115	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000519	0.00115	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—multiple sclerosis	0.000518	0.00114	CcSEcCtD
Tapentadol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000517	0.00114	CcSEcCtD
Tapentadol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000516	0.00114	CcSEcCtD
Tapentadol—Anxiety—Prednisone—multiple sclerosis	0.000516	0.00114	CcSEcCtD
Tapentadol—Insomnia—Betamethasone—multiple sclerosis	0.000515	0.00114	CcSEcCtD
Tapentadol—Insomnia—Dexamethasone—multiple sclerosis	0.000515	0.00114	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000514	0.00114	CcSEcCtD
Tapentadol—Paraesthesia—Betamethasone—multiple sclerosis	0.000512	0.00113	CcSEcCtD
Tapentadol—Paraesthesia—Dexamethasone—multiple sclerosis	0.000512	0.00113	CcSEcCtD
Tapentadol—Mental disorder—Methotrexate—multiple sclerosis	0.000511	0.00113	CcSEcCtD
Tapentadol—Malnutrition—Methotrexate—multiple sclerosis	0.000508	0.00112	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000503	0.00111	CcSEcCtD
Tapentadol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000501	0.00111	CcSEcCtD
Tapentadol—Dyspepsia—Betamethasone—multiple sclerosis	0.000501	0.00111	CcSEcCtD
Tapentadol—Urticaria—Triamcinolone—multiple sclerosis	0.000499	0.0011	CcSEcCtD
Tapentadol—Urticaria—Methylprednisolone—multiple sclerosis	0.000498	0.0011	CcSEcCtD
Tapentadol—Oedema—Prednisone—multiple sclerosis	0.000496	0.0011	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—multiple sclerosis	0.000496	0.0011	CcSEcCtD
Tapentadol—Decreased appetite—Betamethasone—multiple sclerosis	0.000495	0.00109	CcSEcCtD
Tapentadol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000495	0.00109	CcSEcCtD
Tapentadol—Nausea—Mitoxantrone—multiple sclerosis	0.000494	0.00109	CcSEcCtD
Tapentadol—Infection—Prednisone—multiple sclerosis	0.000493	0.00109	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000492	0.00109	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000492	0.00109	CcSEcCtD
Tapentadol—Fatigue—Dexamethasone—multiple sclerosis	0.000491	0.00109	CcSEcCtD
Tapentadol—Fatigue—Betamethasone—multiple sclerosis	0.000491	0.00109	CcSEcCtD
Tapentadol—Shock—Prednisone—multiple sclerosis	0.000488	0.00108	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—multiple sclerosis	0.000487	0.00108	CcSEcCtD
Tapentadol—Tachycardia—Prednisone—multiple sclerosis	0.000484	0.00107	CcSEcCtD
Tapentadol—Skin disorder—Prednisone—multiple sclerosis	0.000482	0.00107	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—multiple sclerosis	0.00048	0.00106	CcSEcCtD
Tapentadol—Vision blurred—Methotrexate—multiple sclerosis	0.000479	0.00106	CcSEcCtD
Tapentadol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000469	0.00104	CcSEcCtD
Tapentadol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000469	0.00104	CcSEcCtD
Tapentadol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000463	0.00102	CcSEcCtD
Tapentadol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000462	0.00102	CcSEcCtD
Tapentadol—Vertigo—Methotrexate—multiple sclerosis	0.000456	0.00101	CcSEcCtD
Tapentadol—Urticaria—Betamethasone—multiple sclerosis	0.000453	0.001	CcSEcCtD
Tapentadol—Urticaria—Dexamethasone—multiple sclerosis	0.000453	0.001	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000452	0.000999	CcSEcCtD
Tapentadol—Dizziness—Prednisolone—multiple sclerosis	0.000451	0.000998	CcSEcCtD
Tapentadol—Asthenia—Triamcinolone—multiple sclerosis	0.00045	0.000996	CcSEcCtD
Tapentadol—Asthenia—Methylprednisolone—multiple sclerosis	0.000449	0.000994	CcSEcCtD
Tapentadol—Insomnia—Prednisone—multiple sclerosis	0.000449	0.000992	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—multiple sclerosis	0.000445	0.000985	CcSEcCtD
Tapentadol—Pruritus—Triamcinolone—multiple sclerosis	0.000444	0.000982	CcSEcCtD
Tapentadol—Cough—Methotrexate—multiple sclerosis	0.000443	0.00098	CcSEcCtD
Tapentadol—Pruritus—Methylprednisolone—multiple sclerosis	0.000443	0.00098	CcSEcCtD
Tapentadol—Convulsion—Methotrexate—multiple sclerosis	0.00044	0.000973	CcSEcCtD
Tapentadol—Dyspepsia—Prednisone—multiple sclerosis	0.000437	0.000965	CcSEcCtD
Tapentadol—Arthralgia—Methotrexate—multiple sclerosis	0.000433	0.000956	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—multiple sclerosis	0.000431	0.000953	CcSEcCtD
Tapentadol—Rash—Prednisolone—multiple sclerosis	0.00043	0.000952	CcSEcCtD
Tapentadol—Dermatitis—Prednisolone—multiple sclerosis	0.00043	0.000951	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00043	0.00095	CcSEcCtD
Tapentadol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000429	0.000948	CcSEcCtD
Tapentadol—Fatigue—Prednisone—multiple sclerosis	0.000428	0.000946	CcSEcCtD
Tapentadol—Headache—Prednisolone—multiple sclerosis	0.000428	0.000946	CcSEcCtD
Tapentadol—Constipation—Prednisone—multiple sclerosis	0.000424	0.000938	CcSEcCtD
Tapentadol—Confusional state—Methotrexate—multiple sclerosis	0.000418	0.000924	CcSEcCtD
Tapentadol—Dizziness—Triamcinolone—multiple sclerosis	0.000415	0.000918	CcSEcCtD
Tapentadol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000415	0.000917	CcSEcCtD
Tapentadol—Dizziness—Methylprednisolone—multiple sclerosis	0.000414	0.000916	CcSEcCtD
Tapentadol—Infection—Methotrexate—multiple sclerosis	0.000412	0.000911	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisone—multiple sclerosis	0.000409	0.000904	CcSEcCtD
Tapentadol—Asthenia—Dexamethasone—multiple sclerosis	0.000409	0.000904	CcSEcCtD
Tapentadol—Asthenia—Betamethasone—multiple sclerosis	0.000409	0.000904	CcSEcCtD
Tapentadol—Nervous system disorder—Methotrexate—multiple sclerosis	0.000407	0.000899	CcSEcCtD
Tapentadol—Nausea—Prednisolone—multiple sclerosis	0.000406	0.000897	CcSEcCtD
Tapentadol—Pruritus—Dexamethasone—multiple sclerosis	0.000403	0.000891	CcSEcCtD
Tapentadol—Pruritus—Betamethasone—multiple sclerosis	0.000403	0.000891	CcSEcCtD
Tapentadol—Skin disorder—Methotrexate—multiple sclerosis	0.000403	0.00089	CcSEcCtD
Tapentadol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000401	0.000886	CcSEcCtD
Tapentadol—Vomiting—Triamcinolone—multiple sclerosis	0.000399	0.000883	CcSEcCtD
Tapentadol—Vomiting—Methylprednisolone—multiple sclerosis	0.000398	0.000881	CcSEcCtD
Tapentadol—Rash—Triamcinolone—multiple sclerosis	0.000396	0.000875	CcSEcCtD
Tapentadol—Dermatitis—Triamcinolone—multiple sclerosis	0.000395	0.000874	CcSEcCtD
Tapentadol—Rash—Methylprednisolone—multiple sclerosis	0.000395	0.000873	CcSEcCtD
Tapentadol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000395	0.000872	CcSEcCtD
Tapentadol—Urticaria—Prednisone—multiple sclerosis	0.000394	0.000871	CcSEcCtD
Tapentadol—Headache—Triamcinolone—multiple sclerosis	0.000393	0.00087	CcSEcCtD
Tapentadol—Headache—Methylprednisolone—multiple sclerosis	0.000392	0.000868	CcSEcCtD
Tapentadol—Diarrhoea—Betamethasone—multiple sclerosis	0.00039	0.000862	CcSEcCtD
Tapentadol—Diarrhoea—Dexamethasone—multiple sclerosis	0.00039	0.000862	CcSEcCtD
Tapentadol—Hypotension—Methotrexate—multiple sclerosis	0.000387	0.000857	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000378	0.000835	CcSEcCtD
Tapentadol—Dizziness—Betamethasone—multiple sclerosis	0.000377	0.000833	CcSEcCtD
Tapentadol—Dizziness—Dexamethasone—multiple sclerosis	0.000377	0.000833	CcSEcCtD
Tapentadol—Insomnia—Methotrexate—multiple sclerosis	0.000375	0.000829	CcSEcCtD
Tapentadol—Nausea—Triamcinolone—multiple sclerosis	0.000373	0.000824	CcSEcCtD
Tapentadol—Paraesthesia—Methotrexate—multiple sclerosis	0.000372	0.000823	CcSEcCtD
Tapentadol—Nausea—Methylprednisolone—multiple sclerosis	0.000372	0.000823	CcSEcCtD
Tapentadol—Dyspnoea—Methotrexate—multiple sclerosis	0.00037	0.000817	CcSEcCtD
Tapentadol—Somnolence—Methotrexate—multiple sclerosis	0.000369	0.000815	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisone—multiple sclerosis	0.000366	0.000808	CcSEcCtD
Tapentadol—Dyspepsia—Methotrexate—multiple sclerosis	0.000365	0.000807	CcSEcCtD
Tapentadol—Vomiting—Dexamethasone—multiple sclerosis	0.000362	0.000801	CcSEcCtD
Tapentadol—Vomiting—Betamethasone—multiple sclerosis	0.000362	0.000801	CcSEcCtD
Tapentadol—Decreased appetite—Methotrexate—multiple sclerosis	0.00036	0.000797	CcSEcCtD
Tapentadol—Rash—Dexamethasone—multiple sclerosis	0.000359	0.000794	CcSEcCtD
Tapentadol—Rash—Betamethasone—multiple sclerosis	0.000359	0.000794	CcSEcCtD
Tapentadol—Dermatitis—Dexamethasone—multiple sclerosis	0.000359	0.000793	CcSEcCtD
Tapentadol—Dermatitis—Betamethasone—multiple sclerosis	0.000359	0.000793	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000358	0.000791	CcSEcCtD
Tapentadol—Fatigue—Methotrexate—multiple sclerosis	0.000357	0.00079	CcSEcCtD
Tapentadol—Headache—Betamethasone—multiple sclerosis	0.000357	0.000789	CcSEcCtD
Tapentadol—Headache—Dexamethasone—multiple sclerosis	0.000357	0.000789	CcSEcCtD
Tapentadol—Asthenia—Prednisone—multiple sclerosis	0.000356	0.000787	CcSEcCtD
Tapentadol—Pruritus—Prednisone—multiple sclerosis	0.000351	0.000776	CcSEcCtD
Tapentadol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000342	0.000755	CcSEcCtD
Tapentadol—Diarrhoea—Prednisone—multiple sclerosis	0.000339	0.00075	CcSEcCtD
Tapentadol—Nausea—Dexamethasone—multiple sclerosis	0.000338	0.000748	CcSEcCtD
Tapentadol—Nausea—Betamethasone—multiple sclerosis	0.000338	0.000748	CcSEcCtD
Tapentadol—Urticaria—Methotrexate—multiple sclerosis	0.000329	0.000728	CcSEcCtD
Tapentadol—Dizziness—Prednisone—multiple sclerosis	0.000328	0.000725	CcSEcCtD
Tapentadol—Vomiting—Prednisone—multiple sclerosis	0.000315	0.000697	CcSEcCtD
Tapentadol—Rash—Prednisone—multiple sclerosis	0.000313	0.000692	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—multiple sclerosis	0.000313	0.000691	CcSEcCtD
Tapentadol—Headache—Prednisone—multiple sclerosis	0.000311	0.000687	CcSEcCtD
Tapentadol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000305	0.000675	CcSEcCtD
Tapentadol—Asthenia—Methotrexate—multiple sclerosis	0.000297	0.000658	CcSEcCtD
Tapentadol—Nausea—Prednisone—multiple sclerosis	0.000295	0.000651	CcSEcCtD
Tapentadol—Pruritus—Methotrexate—multiple sclerosis	0.000293	0.000649	CcSEcCtD
Tapentadol—Diarrhoea—Methotrexate—multiple sclerosis	0.000284	0.000627	CcSEcCtD
Tapentadol—Dizziness—Methotrexate—multiple sclerosis	0.000274	0.000606	CcSEcCtD
Tapentadol—Vomiting—Methotrexate—multiple sclerosis	0.000264	0.000583	CcSEcCtD
Tapentadol—Rash—Methotrexate—multiple sclerosis	0.000261	0.000578	CcSEcCtD
Tapentadol—Dermatitis—Methotrexate—multiple sclerosis	0.000261	0.000577	CcSEcCtD
Tapentadol—Headache—Methotrexate—multiple sclerosis	0.00026	0.000574	CcSEcCtD
Tapentadol—Nausea—Methotrexate—multiple sclerosis	0.000246	0.000544	CcSEcCtD
Tapentadol—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000172	0.00088	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000172	0.000879	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	0.000172	0.000878	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	0.000172	0.000878	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000168	0.000859	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000168	0.000858	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000165	0.000845	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000165	0.000845	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000165	0.000843	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000165	0.000843	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000162	0.000829	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000162	0.000828	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000161	0.000824	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—RRM1—multiple sclerosis	0.00016	0.000819	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000159	0.000815	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000159	0.00081	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000159	0.00081	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000158	0.000807	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000158	0.000807	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GPC5—multiple sclerosis	0.000157	0.000803	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.000156	0.000799	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	0.000155	0.000791	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000154	0.000788	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000153	0.00078	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.000152	0.000777	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000152	0.000775	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000151	0.000773	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	0.000149	0.00076	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000148	0.000757	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000147	0.000753	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000147	0.000753	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000146	0.000747	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000146	0.000745	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000144	0.000734	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000143	0.000733	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000142	0.000727	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000141	0.000719	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000139	0.00071	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000138	0.000708	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000138	0.000704	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000137	0.0007	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000134	0.000685	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000134	0.000684	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000133	0.000682	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000133	0.000679	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000132	0.000676	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000132	0.000675	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.000131	0.000672	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.000131	0.000672	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000131	0.00067	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—RRM1—multiple sclerosis	0.00013	0.000666	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000129	0.00066	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000129	0.000658	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000129	0.000657	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000128	0.000653	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000126	0.000644	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000126	0.000643	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000125	0.000636	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000123	0.000631	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000121	0.000617	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00012	0.000615	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000119	0.000609	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000117	0.0006	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000117	0.000598	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000116	0.000593	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000115	0.000589	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000115	0.000589	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000115	0.000588	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SRM—multiple sclerosis	0.000115	0.000586	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000113	0.000578	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000113	0.000577	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000112	0.000574	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000109	0.000558	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000108	0.000552	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000107	0.000544	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000106	0.000543	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—POMC—multiple sclerosis	0.000106	0.000543	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SRM—multiple sclerosis	0.000105	0.000539	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	0.000105	0.000537	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000105	0.000534	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000104	0.000534	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000104	0.000533	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.000103	0.000524	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000102	0.000521	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000102	0.00052	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000101	0.000516	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.0001	0.000512	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	9.9e-05	0.000506	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	9.81e-05	0.000501	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—POMC—multiple sclerosis	9.77e-05	0.000499	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	9.74e-05	0.000498	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	9.74e-05	0.000498	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	9.72e-05	0.000497	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—POMC—multiple sclerosis	9.69e-05	0.000495	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	9.37e-05	0.000479	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	9.24e-05	0.000472	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—BCHE—multiple sclerosis	9.21e-05	0.00047	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	9.11e-05	0.000465	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	9.02e-05	0.000461	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	8.99e-05	0.00046	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	8.92e-05	0.000456	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PGR—multiple sclerosis	8.88e-05	0.000454	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	8.83e-05	0.000451	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	8.79e-05	0.000449	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	8.71e-05	0.000445	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.68e-05	0.000444	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CD28—multiple sclerosis	8.63e-05	0.000441	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	8.47e-05	0.000433	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	8.37e-05	0.000428	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	8.21e-05	0.00042	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	8.1e-05	0.000414	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	8.08e-05	0.000413	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	8.08e-05	0.000413	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	7.98e-05	0.000408	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	7.95e-05	0.000406	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.91e-05	0.000404	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	7.91e-05	0.000404	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.9e-05	0.000403	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.84e-05	0.000401	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	7.82e-05	0.000399	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PGR—multiple sclerosis	7.79e-05	0.000398	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	7.63e-05	0.00039	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	7.6e-05	0.000388	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CD28—multiple sclerosis	7.56e-05	0.000387	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	7.54e-05	0.000385	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—BCHE—multiple sclerosis	7.48e-05	0.000382	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	7.43e-05	0.00038	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	7.43e-05	0.00038	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	7.43e-05	0.00038	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	7.43e-05	0.00038	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GPC5—multiple sclerosis	7.39e-05	0.000378	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	7.37e-05	0.000376	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	7.37e-05	0.000376	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	7.22e-05	0.000369	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.2e-05	0.000368	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	7.07e-05	0.000361	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	7.04e-05	0.00036	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	6.97e-05	0.000356	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	6.94e-05	0.000355	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	6.85e-05	0.00035	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	6.85e-05	0.00035	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GPC5—multiple sclerosis	6.8e-05	0.000347	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	6.75e-05	0.000345	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GPC5—multiple sclerosis	6.74e-05	0.000344	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	6.68e-05	0.000341	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PGR—multiple sclerosis	6.58e-05	0.000336	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	6.45e-05	0.00033	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	6.42e-05	0.000328	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CD28—multiple sclerosis	6.39e-05	0.000327	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	6.33e-05	0.000324	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	6.28e-05	0.000321	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	6.2e-05	0.000317	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	6.17e-05	0.000315	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CD86—multiple sclerosis	6.15e-05	0.000315	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—RRM1—multiple sclerosis	6.12e-05	0.000313	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	6.06e-05	0.00031	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	5.89e-05	0.000301	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	5.88e-05	0.0003	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	5.79e-05	0.000296	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—RRM1—multiple sclerosis	5.63e-05	0.000288	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	5.63e-05	0.000287	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	5.61e-05	0.000287	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—RRM1—multiple sclerosis	5.58e-05	0.000285	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOE—multiple sclerosis	5.54e-05	0.000283	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	5.46e-05	0.000279	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CD86—multiple sclerosis	5.4e-05	0.000276	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	5.38e-05	0.000275	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	5.35e-05	0.000273	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	5.34e-05	0.000273	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	5.31e-05	0.000271	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	5.24e-05	0.000268	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	5.22e-05	0.000267	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	5.15e-05	0.000263	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOE—multiple sclerosis	4.97e-05	0.000254	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	4.92e-05	0.000251	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	4.79e-05	0.000245	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—multiple sclerosis	4.76e-05	0.000243	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	4.75e-05	0.000243	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.75e-05	0.000243	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	4.72e-05	0.000241	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	4.68e-05	0.000239	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CD86—multiple sclerosis	4.56e-05	0.000233	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOE—multiple sclerosis	4.5e-05	0.00023	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	4.49e-05	0.000229	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CD80—multiple sclerosis	4.49e-05	0.000229	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	4.36e-05	0.000223	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOE—multiple sclerosis	4.35e-05	0.000223	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—multiple sclerosis	4.34e-05	0.000222	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.33e-05	0.000221	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—multiple sclerosis	4.27e-05	0.000218	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	4.17e-05	0.000213	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	4.16e-05	0.000212	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	4.08e-05	0.000209	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.08e-05	0.000209	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	4.04e-05	0.000207	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	3.99e-05	0.000204	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	3.96e-05	0.000202	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CD80—multiple sclerosis	3.94e-05	0.000201	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—multiple sclerosis	3.87e-05	0.000198	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	3.79e-05	0.000194	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—multiple sclerosis	3.74e-05	0.000191	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.72e-05	0.00019	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.72e-05	0.00019	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—multiple sclerosis	3.68e-05	0.000188	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	3.66e-05	0.000187	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	3.58e-05	0.000183	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—multiple sclerosis	3.52e-05	0.00018	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—BCHE—multiple sclerosis	3.52e-05	0.00018	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.39e-05	0.000173	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CD80—multiple sclerosis	3.33e-05	0.00017	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	3.32e-05	0.00017	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—BCHE—multiple sclerosis	3.23e-05	0.000165	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.21e-05	0.000164	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—multiple sclerosis	3.16e-05	0.000162	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—multiple sclerosis	3.15e-05	0.000161	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	3.14e-05	0.00016	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	3.09e-05	0.000158	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	3.03e-05	0.000155	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	2.98e-05	0.000153	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	2.81e-05	0.000144	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—multiple sclerosis	2.77e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	2.75e-05	0.000141	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	2.65e-05	0.000136	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	2.62e-05	0.000134	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MYC—multiple sclerosis	2.47e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	2.46e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	2.41e-05	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—multiple sclerosis	2.34e-05	0.000119	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	2.33e-05	0.000119	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	2.33e-05	0.000119	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	2.21e-05	0.000113	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MYC—multiple sclerosis	2.16e-05	0.000111	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	2.16e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	2.12e-05	0.000108	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—multiple sclerosis	2.12e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	1.97e-05	0.000101	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—multiple sclerosis	1.95e-05	9.94e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—multiple sclerosis	1.93e-05	9.86e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—multiple sclerosis	1.85e-05	9.47e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MYC—multiple sclerosis	1.83e-05	9.34e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.82e-05	9.32e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—multiple sclerosis	1.82e-05	9.29e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.79e-05	9.14e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—multiple sclerosis	1.67e-05	8.54e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—multiple sclerosis	1.66e-05	8.47e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—multiple sclerosis	1.66e-05	8.47e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—multiple sclerosis	1.63e-05	8.31e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—multiple sclerosis	1.52e-05	7.79e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—multiple sclerosis	1.51e-05	7.72e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—multiple sclerosis	1.37e-05	7.02e-05	CbGpPWpGaD
